Chad K. Biski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Chad K. Biski has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Michele Caggana
Newborn Screening Program, Division of Genetics, Wadsworth Center, New York State Department of Health, Albany, NY
3 shared publicationsWei-Lien Chuang
Genzyme Corporation, Framingham, MA 01701-09322, United States
2 shared publicationsX. Kate Zhang
2 shared publicationsAllison J. Young
Newborn Screening Program, Division of Genetics, Wadsworth Center, New York State Department of Health, Albany, NY
1 shared publicationApril L. Parker
Newborn Screening Program, Division of Genetics, Wadsworth Center, New York State Department of Health, Albany, NY
1 shared publication- Carlos A Saavedra-Matiz
Newborn Screening Program, Division of Genetics, Wadsworth Center, New York State Department of Health, Albany, NY 12201, USA
1 shared publication
Latest Publications
- 1 July 2013
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 59 (7) , 1045-1051
Cost-Effective and Scalable DNA Extraction Method from Dried Blood Spots
BACKGROUND: Dried blood spot (DBS) samples have been widely used in newborn screening (NBS) for the early identification of disease to facilitate the presymptomatic treatment of congenital diseases in newborns. As molecular genetics knowledge and technology progresses, there is an increased demand on NBS programs for molecular testing and a need to establish reliable, low-cost methods to perform those analyses. Here we report a flexible, cost-efficient, high-throughput DNA extraction method from DBS adaptable to small- and large-scale screening settings.METHODS: Genomic DNA (g.DNA) was extracted from single 3-mm diameter DBS by the sequential use of red cell lysis, detergent-alkaline, and acid-neutralizing buffers routinely used in whole blood and plant tissue DNA extractions. We performed PCR amplification of several genomic regions using standard PCR conditions and detection methods (agarose gel, melting-curve analysis, TaqMan-based assays). Amplicons were confirmed by BigDye® Terminator cycle sequencing and compared with reference sequences.RESULTS: High-quality g.DNA was extracted from hundreds of DBS, as proven by mutation detection of several human genes on multiple platforms. Manual and automated extraction protocols were validated. Quantification of g.DNA by Oligreen® fluorescent nucleic acid stain demonstrated a normal population distribution closely corresponding with white blood cell counts detected in newborn populations.CONCLUSIONS: High-quality, amplifiable g.DNA is extractable from DBSs. Our method is adaptable, reliable, and scalable to low- and high-throughput NBS at low cost ($0.10/sample). This method is routinely used for molecular testing in the New York State NBS program.
- 1 July 2013
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 59 (7) , 1045-1051
Cost-Effective and Scalable DNA Extraction Method from Dried Blood Spots
BACKGROUND: Dried blood spot (DBS) samples have been widely used in newborn screening (NBS) for the early identification of disease to facilitate the presymptomatic treatment of congenital diseases in newborns. As molecular genetics knowledge and technology progresses, there is an increased demand on NBS programs for molecular testing and a need to establish reliable, low-cost methods to perform those analyses. Here we report a flexible, cost-efficient, high-throughput DNA extraction method from DBS adaptable to small- and large-scale screening settings.METHODS: Genomic DNA (g.DNA) was extracted from single 3-mm diameter DBS by the sequential use of red cell lysis, detergent-alkaline, and acid-neutralizing buffers routinely used in whole blood and plant tissue DNA extractions. We performed PCR amplification of several genomic regions using standard PCR conditions and detection methods (agarose gel, melting-curve analysis, TaqMan-based assays). Amplicons were confirmed by BigDye® Terminator cycle sequencing and compared with reference sequences.RESULTS: High-quality g.DNA was extracted from hundreds of DBS, as proven by mutation detection of several human genes on multiple platforms. Manual and automated extraction protocols were validated. Quantification of g.DNA by Oligreen® fluorescent nucleic acid stain demonstrated a normal population distribution closely corresponding with white blood cell counts detected in newborn populations.CONCLUSIONS: High-quality, amplifiable g.DNA is extractable from DBSs. Our method is adaptable, reliable, and scalable to low- and high-throughput NBS at low cost ($0.10/sample). This method is routinely used for molecular testing in the New York State NBS program.
- 1 April 2013
- Published by Elsevier in Clinica Chimica Acta
- Vol. 419, 73-76
Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease
- 1 April 2013
- Published by Elsevier in Clinica Chimica Acta
- Vol. 419, 73-76
Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease
- 1 June 2009
- Published by Elsevier in Clinical Biochemistry
- Vol. 42 (9) , 877-884
Implementation of newborn screening for Krabbe disease: Population study and cutoff determination
- 1 June 2009
- Published by Elsevier in Clinical Biochemistry
- Vol. 42 (9) , 877-884
Implementation of newborn screening for Krabbe disease: Population study and cutoff determination